Scalp Psoriasis

Immunology

Prevalence

3000.0 / 100K

Incidence

78.0 / 100K/yr

4 drugs in development·1 company·2 clinical trials

Drug Pipeline by Phase

Compare drugs

ZORYVE (roflumilast) topical foam 0.3% vs ZORYVE foam (ARQ-151)ZORYVE (roflumilast) topical foam 0.3% vs Roflumilast Foam 0.3%ZORYVE (roflumilast) topical foam 0.3% vs Vehicle Foam

Frequently asked questions

How many drugs are in development for Scalp Psoriasis?

BioSniper tracks 4 drugs in development for Scalp Psoriasis across 1 company.

How many clinical trials target Scalp Psoriasis?

There are 2 clinical trials targeting Scalp Psoriasis tracked by BioSniper.

What is the prevalence of Scalp Psoriasis?

The estimated prevalence of Scalp Psoriasis is approximately 3000.0 per 100,000 population.

Deep-dive into Scalp Psoriasis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Scalp Psoriasis — Drugs in Development & Clinical Trials | BioSniper